Literature DB >> 23523591

Tu-be or not tu-be: that is the question… about serous ovarian carcinogenesis.

G Chene1, J Dauplat, N Radosevic-Robin, A Cayre, F Penault-Llorca.   

Abstract

Our understanding of the early natural history of epithelial ovarian carcinoma is limited by the access to early lesions as the disease is very often diagnosed at advanced stages. The incessant ovulation theory from the last century that indicated the ovary as the site for the initiation of high-grade serous cancers is contrary to the newly emerging idea that ovarian cancer could arise from the distal fallopian tube. In view of the recent pathological and molecular studies, we propose to discuss the genesis of high-grade serous ovarian cancer.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fallopian tube; Ovarian cancer; Ovarian carcinogenesis; Ovarian dysplasia; STIC; Serous tubal intraepithelial carcinoma

Mesh:

Year:  2013        PMID: 23523591     DOI: 10.1016/j.critrevonc.2013.03.004

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  14 in total

1.  Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomes.

Authors:  Miriam Rottmann; A Burges; S Mahner; C Anthuber; T Beck; D Grab; A Schnelzer; M Kiechle; D Mayr; M Pölcher; G Schubert-Fritschle; J Engel
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-26       Impact factor: 4.553

2.  Primary peritoneal cancer in BRCA carriers after prophylactic bilateral salpingo-oophorectomy.

Authors:  Christos Iavazzo; Ioannis D Gkegkes; Nikolaos Vrachnis
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-01-12

3.  Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course.

Authors:  An Coosemans; Judit Decoene; Thaïs Baert; Annouschka Laenen; Ahmad Kasran; Tina Verschuere; Sven Seys; Ignace Vergote
Journal:  Oncoimmunology       Date:  2015-12-21       Impact factor: 8.110

Review 4.  Recent concepts of ovarian carcinogenesis: type I and type II.

Authors:  Masafumi Koshiyama; Noriomi Matsumura; Ikuo Konishi
Journal:  Biomed Res Int       Date:  2014-04-23       Impact factor: 3.411

5.  Primary carcinoma of the fallopian tubes: Analysis of sixteen patients.

Authors:  Meryem Eken; Osman Temizkan; Ecmel Işık Kaygusuz; Dilşad Herkiloğlu; Ebru Çöğendez; Ateş Karateke
Journal:  Turk J Obstet Gynecol       Date:  2015-06-15

Review 6.  Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.

Authors:  Yuliya Klymenko; Oleg Kim; M Sharon Stack
Journal:  Cancers (Basel)       Date:  2017-08-09       Impact factor: 6.639

7.  Expression of Stem Cell Markers in Preinvasive Tubal Lesions of Ovarian Carcinoma.

Authors:  G Chene; V Ouellet; K Rahimi; V Barres; L Meunier; M De Ladurantaye; D Provencher; A M Mes-Masson
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

Review 8.  Early preinvasive lesions in ovarian cancer.

Authors:  Gautier Chene; Gery Lamblin; Karine Le Bail-Carval; Philippe Chabert; Naoual Bakrin; Georges Mellier
Journal:  Biomed Res Int       Date:  2014-04-08       Impact factor: 3.411

Review 9.  Refractory fallopian tube carcinoma - current perspectives in pathogenesis and management.

Authors:  Ashwin R Sama; Russell J Schilder
Journal:  Int J Womens Health       Date:  2014-01-28

10.  Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen.

Authors:  G Chene; N Radosevic-Robin; A S Tardieu; A Cayre; I Raoelfils; P Dechelotte; J Dauplat; F Penault Llorca
Journal:  Eur J Histochem       Date:  2014-04-15       Impact factor: 3.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.